Episodit
-
This is a repost of a popular episode of MAP - Market Access Podcast, from December 15th 2021.
Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the former head of the AMNOG arbitration board and the current head of the DiGA arbitration board.
In this wide ranging conversation Dr. Stefan Walzer confronted Prof. Wasem with in-depth issues to take the arbitration board as well into strategic considerations.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketacces4-0.de
www.marketaccess4-0.com/
#MarketAccess #marketaccess #marketaccesspodcast
-
This is a repost of a popular episode of MAP - Market Access Podcast, from April 15th 2023.
All patients within all populations should have access to high quality medications that improve their health outcomes regardless of race, ethnicity, socio-economic status or any other individual factors, wrote Dr. Utibe R. Essien in an Jama article 2021. But how does reality look like? Equality in access starts with the generalizability of RCT data and the inclusion and exclusion criteria for these studies. But it does not stop there. How do regulators, payers and physicians work against inequality? The market access veteran Dr. Stefan Walzer and the Canadian health economist Dr. Nina Lathia have discussed these pharmacoequity issues from a global perspective. What does this mean for drug development? What does this mean for clinical trials?
Let’s not leave these questions with politicians alone. The voice from all stakeholders is needed and wanted.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketacces4-0.de
www.marketaccess4-0.com/
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #Canada #pharmacoequity #pharma #healthcare
-
Puuttuva jakso?
-
This is a repost of a popular episode of MAP - Market Access Podcast, from October 1st 2022.
Digital health could improve the efficiency, care and way patients are treated in all health care systems in the next years. Germany has started by implementing digital health applications (“DIGAs”) and is currently on its way to improve the digital infrastructure in hospitals. Anyway, some core questions remain such as reimbursement for high risk medical devices, e.g. artificial intelligence (AI), interoperability.
Dr. Stefan Walzer and Julian Molitor are discussing the current state as well as future opportunities with digital tools across the health care system. If you need to know where the German adoption is with respect to digitization you should not miss this podcast episode.
Stay updated for upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #digitalisation #germany
-
This is a repost of a popular episode of MAP, Market Access Podcast, from 15th of July 2023.
Even though there are great accelerators and a lot of innovative product ideas, only very few products actually make it to the market and are commercially successful. What is the reason behind that and even more important how could this situation be improved?
In this podcast episode, Dr. Stefan Walzer and Dr. Kasia Hein-Peters are discussing the necessity for an overarching business and company strategy approach. In health care this is sometimes referred to a lifecycle approach, the invented approach by Dr. Kasia Hein-Peters is called DIVE. Within these approaches, all stakeholders would always need to be captured and dealt with - clinical development, regulatory and payers.
Stay updated for upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #innovation #pricing #drugs #medtech #livescience #strategy
-
Join us on the latest episode of MAP - the Market Access Podcast - where our host Dr. Stefan Walzer, together with special guest Gerdi Strydom, Managing Director at Valid Insight, explore the integration of ESG (Environmental, Social, and Governance) into Health Technology Assessments (HTAs).
In this episode, they unpack how healthcare's carbon footprint and environmental impact are influencing policy, payor decisions, and industry strategies. Discover how leaders are addressing these challenges, the steps being taken in regions like the Nordics and the UK, and what the future holds for low-carbon pharmaceuticals.
This episode is for anyone who wants to get a better understanding of the growing role of environmental factors in HTAs as well as how global collaboration can drive sustainability in healthcare. Stay ahead of the trends in market access, and join the conversation around sustainability’s role in healthcare. Tune in now!
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketacces4-0.de
www.marketaccess4-0.com/
#MarketAccess #HealthcareInnovation #Sustainability #HTA #Pharma #ESG #marketaccess #marketaccesspodcast
-
This is a repost of a popular MAP, Market Access Podcast, from 1st of January 2023.
Companies launching oncology drugs sometimes struggle with existing reimbursement pathways and negotiations with payers, mainly in Europe, but also in other parts of the world. Evidence generation is the start of every drug development, but especially in oncology the design is important – not only that payers want to get a proof of a longer survival, but they also have further needs in their internal assessment. Enjoy the insights shared by the oncology market access veterans Dr. Stefan Walzer and Ed Schoonveld.
Stay updated for upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #germany #Europe #oncology
-
This is a repost of a popular MAP, Market Access Podcast, from January 2023.
A strong evidence package is important as a solid base for health technology assessments and the following price negotiations with health care payers. It is widely agreed, that randomized controlled trials are the gold standard in HTA, but there are also strong advocates of real-world evidence as a complementary way to measure the effectiveness of treatments.
One of these advocates is Dr. Karen Facey and so Dr. Stefan Walzer brought her on the podcast and asked all the tough questions about real world evidence and the reality with payers around the world. Are there opportunities in such RWE data or is that a dead-end?
Take the chance to stay connected and subscribe with your favourite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketacces4-0.de
www.marketaccess4-0.com/
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #hta #pharma #healthcare #realworldevidence #rwe
-
In this repost of MAP, the Market Access Podcast, from 15th of September 2023, you’ll hear from Dr Stefan Walzer and Dr Mike Rosenblatt as they’re discussing the age we are currently in of massive medical innovation, including a lot of new modalities especially in the area of ATMPs, and this insightful conversation highlights some core questions:
- What are the differences between Clinical Development and Medical Affairs?
- When should a company start telling their medical story about a new product?
- What are the differences between drugs and vaccinations from a medical affairs’ perspective?
- ... and how should market access and medical affairs ideally work together?
Tune in to listen to the Market Access veteran Dr. Stefan Walzer and Dr. Mike Rosenblatt, one of the pioneers in Medical Affairs, Commercialisation and Market Access, as they continued their conversation from Boston, May 2023, through this epic podcast episode.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketacces4-0.de
www.marketaccess4-0.com/
#Medtech #MarketAccess #US #HealthcareSystem #marketaccess #marketaccesspodcast #pricing #medtech #pharmaceuticals #innovation #vaccination
-
Tune in to the latest episode of MAP, the Market Access Podcast, hosted by Dr Stefan Walzer. In this summer special you will hear some profound insights from the recent MArS Webinar about the new platform DO-Bo - the first and only AI bot for creating reimbursement dossiers globally. Alongside Dr. Stefan Walzer you will also hear from Aleksey Zavgorodniy from Ukraine as they dive deep into how large language models are revolutionizing healthcare dossier writing.
The journey to create DO-Bo highlighted unique challenges and innovative solutions. Integrating expert knowledge with AI, maintaining data security, and optimizing data processing were key to DO-Bo's success. Explore how DO-Bo can save time and enhance quality in your market access strategies. Interested in transforming your dossier writing process? Request a live demo today and witness firsthand how DO-Bo is redefining healthcare dossier creation.
Stay updated about upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/
#Medtech #MarketAccess #DO-Bo #HealthcareSystem #dossierwriting #marketaccess #marketaccesspodcast #dossier #webinar
-
Join us on the latest episode of MAP - the Market Access Podcast - hosted by Dr. Stefan Walzer, as we delve into the dynamic world of market access in Turkey. This episode features Oznur Seyhun, from Market Access Today, who brings expertise from over 20 years of experience in pharmaceutical chemistry, economics, and global management.
Explore the latest trends in healthcare market access in Turkey, and discover how they are adapting to economic challenges like inflation and currency fluctuations. Learn about the introduction of Multi-Criteria Decision Analysis (MCDA) in reimbursement submissions, the rise of digital health solutions, and patient support programs.
This episode is for anyone looking to deepen their understanding of why Turkey remains an attractive market for pharmaceutical companies despite economic pressures, with insights into local manufacturing incentives and the evolving private sector.
Tune in to gain a comprehensive understanding of the current landscape and future prospects of market access in Turkey. Don’t miss out on this insightful discussion!
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: www.marketaccess4-0.com/
#MarketAccess #HealthcareInnovation #DigitalHealth #Turkey #HealthcareSystem #marketaccess #marketaccesspodcast #medtech
-
Unlock the Future of Market Access with AI and Systematic Literature Reviews! Join Dr. Stefan Walzer in the latest episode of the Market Access Podcast as he delves into the transformative power of AI in systematic literature searches. Featuring Jeffrey Johnson and Kevin Kallmes from Nested Knowledge, this episode explores how their innovative platform revolutionizes literature reviews, making them faster, more efficient, and more enjoyable.
This episode is for anyone who wants to learn more about the integration of AI in market access, reimbursement planning, and dossier creation. Tune in to find out how AI is not only saving time but also enhancing the quality of research and market access strategies. Don’t miss this insightful discussion on the future of AI in healthcare!
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: www.marketaccess4-0.com/
#MarketAccess #AI #SystematicReview #HealthcareInnovation #Pharma #marketaccess #marketaccesspodcast
-
Tune in to the new episode of the Market Access Podcast (MAP), where Dr. Stefan Walzer, a pioneer in Market Access 4.0, explores groundbreaking solutions and innovative technologies shaping the future of healthcare reimbursement. Discover how AI-based platforms like Q-Bo and Wafle are revolutionizing health care trainings with all stakeholders.
Special guest Rodrigo Silva shares his insights on the transformative power of virtual reality in healthcare, from enhancing nurse training to potential applications in the pharmaceutical industry. Discover how these technologies are revolutionizing market access and how digital health platforms can address critical healthcare challenges like nursing shortages.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: www.marketaccess4-0.com
#MarketAccess #AI #VirtualReality #HealthcareInnovation #Pharma #marketaccess #marketaccesspodcast #FutureOfHealthcare"
-
In the latest episode of MAP - the Market Access Podcast, Dr. Stefan Walzer discusses the transformative power of AI with industry veteran Sandip Shah. With over three decades in healthcare, Sandip shares his journey from sales rep to running Market Access Solutions, emphasizing on how AI is reshaping the landscape.
Discover how AI is revolutionizing market research, streamlining dossier preparation, and reshaping pricing strategies. This episode is for anyone who wants to dive deep into how the potential of AI in enhancing market research through emotion recognition and data analysis can significantly impact payer research and training for sales reps. Imagine having comprehensive dossiers at your fingertips in the future, reducing preparation time from months to seconds.
Listen now to explore how AI is set to redefine market access, driving efficiency and innovation in ways we've only begun to imagine. Stay ahead of the curve and join the conversation on how AI will shape our industry's future!
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
#MarketAccess #AI #HealthcareInnovation #HealthcareSystem #marketaccess #marketaccesspodcast
-
What will the future of AI in healthcare look like? Join us in the latest episode of MAP, the Market Access Podcast, featuring Alexey Zavgorodniy from Unicsoft, and explore the transformative world of artificial intelligence. With extensive experience in AI and large language models, Alexey shares invaluable insights into how AI is reshaping healthcare, pharmaceuticals, and beyond.
In this episode you will learn how AI mirrors the industrial revolution and how that results in both unique opportunities and challenges. Aleksey also illustrates some real-world applications of AI in market access, from predictive analytics in drug pricing to automated literature reviews and more.
The discussion also goes further into the importance of privacy and ethical considerations that follows AI use, and why it is necessary to ensure data security while maximizing the benefits of technology
Whether you're an industry professional or a tech enthusiast, this episode offers a comprehensive overview of AI's current applications and its potential to drive future innovations in healthcare.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
#ArtificialIntelligence #AIInsights #HealthcareInnovation #Medtech #MarketAccess #HealthcareSystem #MedicalTechnology #marketaccess #marketaccesspodcast #medtech
-
In the newest episode of MAP - the Market Access podcast, experts Tara Cowling and Jody Filkowski unpacks the complexities and nuances of Canada's market access for pharmaceuticals and medical devices. From regulatory hurdles to intricate reimbursement pathways, they shed light on what it takes to successfully navigate this diverse and challenging landscape.
Whether you're dealing with drugs or medical devices, understanding the distinct processes in Canada, including the differences between provinces and the role of private versus public payers, is crucial. This episode offers a deep dive into the practical strategies and real-world challenges faced by industry professionals working within the Canadian healthcare system. They also share insights about the emerging role of digital health in Canada, and the potential changes with the introduction of the Canadian Drug Agency.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
#Medtech #MarketAccess #Canada #Healthcare #marketaccess #marketaccesspodcast #medtech #pharmaceuticals #medicaldevices #digitalhealth
-
What role will AI & VR transformations play in the future? Tune in to this fascinating episode of the Market Access Podcast to hear as our special guest, Glib Kutepov, CEO and founder of Modulate, shares his expertise.
Glib uncovers the potential of generative AI and neural networks in revolutionizing market access strategies and highlights the challenges and solutions around data privacy as well as the integration of private layers to protect sensitive information. He also touches on the role of VR in empathizing with patients' experiences, adding a deeply human element to the data-driven world of market access. This episode will not only provide a deeper understanding for the technology, but also tools of practical ways to implement it.
AI and VR could change the data driven health care in the future, as it can benefit the strategic work as well as assist in ensuring a better understanding for the patients’ experiences. Whether you're a healthcare professional, market access manager, or tech enthusiast, this conversation offers a glimpse into a future where technology enhances our approach to healthcare on multiple levels.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
#HealthcareInnovation #MarketAccess #marketaccesspodcast #ArtificialIntelligence #VirtualReality #FutureOfHealthcare #marketaccess
-
Tune into a brand new episode of the Market Access Podcast to listen to an intriguing conversation about the Italian healthcare system with Giacomo Matteo Bruno and Dr Stefan Walzer. Together they explore the balance between innovation, sustainability, and patient access in the heart of Europe. Discover the evolution, challenges, and future of healthcare in Italy, from the foundational principles laid down in 1978 to the dynamic, ever-evolving landscape of today.
Giacomo shares his insights on how to navigate the crucial role of health economics in drug pathways as well as giving a birds-eye perspective over the healthcare system in Italy today and the challenges that comes with an aging population and rising chronic diseases. Giacomo presents a vision for embracing innovation while maintaining the system’s integrity.
If you are searching for deeper knowledge about the Italian healthcare system and learn about strategies on how to enter the Italian market, this episode is for you. Learn about the regional nuances that make Italy unique, the steps for drug reimbursement, and the importance of targeted therapies in personalized medicine. Giacomo also sheds light on the pioneering electronic dossier system introduced by IFA, streamlining the approval process and setting a new standard in healthcare innovation.
Whether you're a healthcare professional, a pharmaceutical company, or just intrigued by the global healthcare landscape, this conversation offers valuable lessons and strategies for success in one of the world's most revered healthcare systems.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
#HealthcareInnovation #MarketAccess #Italy #ItalianHealthcare #PharmaceuticalIndustry #marketaccesspodcast #marketaccess
-
In this captivating episode of MAP, the Market Access Podcast, we welcome Aymeric Chaupin, a seasoned expert in pricing and market access. Aymeric's unique perspective, shaped by his deep understanding of both the American and European healthcare systems, sheds light on the complexities of healthcare reimbursement pathways in the US and their impact on the delivery of health services.
Join us as Aymeric unveils the challenges and opportunities within the US healthcare market. He emphasizes the importance of coding and understanding reimbursement pathways for effective market access and explores the broader implications for patient care and the healthcare system as a whole.
This episode is a treasure trove of insights for startups and companies looking to navigate the US healthcare landscape. Aymeric shares practical advice on entering the market, from partnering with pharmaceutical giants to engaging with the FDA early in the clinical trial process. He stresses the necessity of having a clear strategy and representation in the US to negotiate coverage and formulary placement, ensuring commercial success in this pivotal market.
Despite the hurdles, the US remains a key player in the global pharmaceutical and medical device industry, accounting for a significant portion of global revenue.
Tune in for an enlightening discussion that navigates the intricacies of the US healthcare system, providing valuable lessons and strategies for companies aspiring to make their mark in this challenging yet rewarding market.
#HealthcareInnovation #MarketAccess #US #USHealthcareSystem #PharmaceuticalIndustry #MedicalDevices #HealthcareReform #marketaccess #marketaccesspodcast
-
Explore the inspiring journey of Dipti Tankala in this podcast episode as she delves into market access within the pharmaceutical industry. From facing challenges in community pharmacy to leading in oncology market access, Dipti shares valuable insights on making impactful career transitions. Market Access veteran Dr. Stefan Walzer and Dipti Tankala also talk about the significance of networking, mentorship, and the essential skills for success. This episode is a must-listen for professionals looking to navigate the complex world of market access and leverage opportunities in the pharmaceutical field. Tune in to unlock your career potential with expert advice from a seasoned market access professional. Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#Medtech #MarketAccess #Canada #HealthcareSystem #marketaccess #marketaccesspodcast #medtech
-
In this essential episode of the Market Access Podcast, we're diving deep into the critical aspects of commercializing healthcare innovations in the US market. Whether you're in medtech, pharma, biotech, or health tech, understanding the US healthcare landscape is key to your product's success. Join us as Dr. Stefan Walzer and Paul-Lukas Hoffschmidt, CEO of Alpha Sophia (www.alphasophia.com), share their wealth of knowledge on effective strategies for navigating this complex terrain.
Key Topics Covered:
Understanding US Market Access: An overview of the unique challenges and opportunities in the US healthcare system for new entrants.Role of Healthcare Professionals: Insight into how healthcare professionals influence market access and product uptake.Data-Driven Strategies: The importance of leveraging data in targeting and positioning your product effectively.Commercialization Pathways: Expert advice on navigating regulatory, reimbursement, and distribution challenges.Case Studies: Real-world examples of successful market entry and the lessons learned.Future Trends: Predictions on how the US market access landscape may evolve and what it means for healthcare innovators.Why You Should Listen:
Gain Expert Insights: Learn from leading experts with firsthand experience in the US healthcare market.Strategic Advice: Receive actionable advice on overcoming the hurdles to market entry and expansion.Stay Ahead: Understand the latest trends and how they impact market access strategies.This episode is indispensable for CEOs, entrepreneurs, market access professionals, and anyone involved in the commercialization of healthcare innovations looking to penetrate or expand their presence in the US market.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
#Medtech #MarketAccess #US #HealthcareSystem #MarketAccessPodcast
- Näytä enemmän
